Onodera Hideyuki, Kaneko Masami, Takahashi Yuichi, Uochi Yumiko, Funahashi Jun, Nakashima Takayuki, Soga Shiro, Suzuki Makoto, Ikeda Shunichi, Yamashita Yoshinori, Rahayu Endang S, Kanda Yutaka, Ichimura Michio
BioFrontier Laboratories, Kyowa Hakko Kogyo Co., Ltd., 3-6-6 Asahi-machi, Machida-shi, Tokyo 194-8533, Japan.
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1588-91. doi: 10.1016/j.bmcl.2008.01.072. Epub 2008 Jan 24.
Hsp90 is an attractive chemotherapeutic target because it is essential to maturation of multiple oncogenes. We describe the conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin isolated from Streptomyces sp. Their native free structures are similar to the active form of geldanamycin bound to Hsp90 protein. Their conformational character is a probable reason for their high-affinity binding. Lack of toxic benzoquinone in EH21A1-A4 also adds to their potential as lead compounds for anti-tumor drugs.
Bioorg Med Chem Lett. 2008-3-1
J Med Chem. 2008-5-8
J Med Chem. 2009-5-28
J Mol Biol. 2007-9-14
J Antibiot (Tokyo). 2011-6
Chem Biol. 2004-12
Chembiochem. 2015-1-19
Bioorg Med Chem Lett. 2011-4-5
Microbiol Spectr. 2022-4-27
Angew Chem Int Ed Engl. 2017-1-31
Bioorg Med Chem Lett. 2009-10-25